Search Results - "Haynes‐Williams, Vanessa"

Dietary fatty acid oxidation is decreased in non‐alcoholic fatty liver disease: A palmitate breath test study by Naguib, Gihan, Morris, Nevitt, Yang, Shanna, Fryzek, Nancy, Haynes‐Williams, Vanessa, Huang, Wen‐Chun A., Norman‐Wheeler, Jaha, Rotman, Yaron

“…Background & Aim Hepatic fat excess in non‐alcoholic fatty liver disease (NAFLD) reflects an imbalance between fat accumulation and disposal. Conflicting data…”
Get full text

Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial by Koh, Christopher, Dr, Canini, Laetitia, PhD, Dahari, Harel, PhD, Zhao, Xiongce, PhD, Uprichard, Susan L, PhD, Haynes-Williams, Vanessa, BSN, Winters, Mark A, MS, Subramanya, Gitanjali, MS, Cooper, Stewart L, MD, Pinto, Peter, MD, Wolff, Erin F, MD, Bishop, Rachel, MD, Ai Thanda Han, Ma, MD, Cotler, Scott J, Prof, Kleiner, David E, MD, Keskin, Onur, MD, Idilman, Ramazan, MD, Yurdaydin, Cihan, Prof, Glenn, Jeffrey S, MD, Heller, Theo, MBBch

“…Summary Background Therapies for chronic hepatitis delta virus (HDV) infection are unsatisfactory. Prenylation is essential for HDV and inhibition abrogates…”
Get full text

Understanding early serum hepatitis D virus and hepatitis B surface antigen kinetics during pegylated interferon‐alpha therapy via mathematical modeling by Guedj, Jeremie, Rotman, Yaron, Cotler, Scott J., Koh, Christopher, Schmid, Peter, Albrecht, Jeff, Haynes‐Williams, Vanessa, Liang, T. Jake, Hoofnagle, Jay H., Heller, Theo, Dahari, Harel

“…There is little information on the early kinetics of hepatitis delta virus (HDV) and hepatitis B surface antigen (HBsAg) during interferon‐α therapy. Here a…”
Get full text

Ribavirin Improves Early Responses to Peginterferon Through Improved Interferon Signaling by Feld, Jordan J, Lutchman, Glen A, Heller, Theo, Hara, Koji, Pfeiffer, Julie K, Leff, Richard D, Meek, Claudia, Rivera, Maria, Ko, Myung, Koh, Christopher, Rotman, Yaron, Ghany, Marc G, Haynes–Williams, Vanessa, Neumann, Avidan U, Liang, T. Jake, Hoofnagle, Jay H

“…Background & Aims The therapeutic mechanisms of ribavirin for hepatitis C are unclear. Microarray analyses have shown that ribavirin increases induction of…”
Get full text

Postprandial Plasma Lipidomics Reveal Specific Alteration of Hepatic-derived Diacylglycerols in Nonalcoholic Fatty Liver Disease by Velenosi, Thomas J., Ben-Yakov, Gil, Podszun, Maren C., Hercun, Julian, Etzion, Ohad, Yang, Shanna, Nadal, Cathy, Haynes-Williams, Vanessa, Huang, Wen-Chun A., González-Hódar, Lila, Brychta, Robert J., Takahashi, Shogo, Akkaraju, Vikas, Krausz, Kristopher W., Walter, Mary, Cai, Hongyi, Walter, Peter J., Muniyappa, Ranganath, Chen, Kong Y., Gonzalez, Frank J., Rotman, Yaron

“…Hepatic energy metabolism is a dynamic process modulated by multiple stimuli. In nonalcoholic fatty liver disease (NAFLD), human studies typically focus on the…”
Get full text

Postprandial plasma lipidomics reveal specific alteration of hepatic-derived diacylglycerols in non-alcoholic fatty liver disease by Velenosi, Thomas J., Ben-Yakov, Gil, Podszun, Maren C., Hercun, Julian, Etzion, Ohad, Yang, Shanna, Nadal, Cathy, Haynes-Williams, Vanessa, Huang, Wen-Chun A., Gonzalez-Hodar, Lila, Brychta, Robert J., Takahashi, Shogo, Akkaraju, Vikas, Krausz, Kristopher W., Walter, Mary, Cai, Hongyi, Walter, Peter J., Muniyappa, Ranganath, Chen, Kong Y., Gonzalez, Frank J., Rotman, Yaron

“…In humans with NAFLD and in mouse models of the disease, mixed-meal leads to selective secretion of diacylglycerols (DAG) from the liver to the plasma through…”
Get full text

Long‐term therapy of chronic delta hepatitis with peginterferon alfa by Heller, T., Rotman, Y., Koh, C., Clark, S., Haynes‐Williams, V., Chang, R., McBurney, R., Schmid, P., Albrecht, J., Kleiner, D. E., Ghany, M. G., Liang, T. J., Hoofnagle, J. H.

“…Summary Background Chronic delta hepatitis virus (HDV) infection rapidly progresses to cirrhosis. Treatment with peginterferon for up to 2 years is often…”
Get full text

Complications of percutaneous liver biopsy with Klatskin needles: a 36‐year single‐centre experience by Takyar, V., Etzion, O., Heller, T., Kleiner, D. E., Rotman, Y., Ghany, M. G., Fryzek, N., Williams, V. H., Rivera, E., Auh, S., Liang, T. J., Hoofnagle, J. H., Koh, C.

“…Summary Background Liver biopsy is the gold standard in evaluating liver diseases but is susceptible to complications. Safety data on aspiration needle…”
Get full text

Spectrum of Liver Disease in Hepatitis B Virus (HBV) Patients Co-infected with Human Immunodeficiency Virus (HIV): Results of the HBV-HIV Cohort Study by Sterling, Richard K, Wahed, Abdus S, King, Wendy C, Kleiner, David E, Khalili, Mandana, Sulkowski, Mark, Chung, Raymond T, Jain, Mamta K, Lisker-Melman, Mauricio, Wong, David K, Ghany, Marc G

“…Because most HBV/HIV co-infected patients on combination antiretroviral therapy (cART) have suppressed HBV DNA and normal liver enzymes, the histologic…”
Get full text

Patient‐reported outcomes in a large North American cohort living with chronic hepatitis B virus: a cross‐sectional analysis by Evon, Donna M., Lin, Hsing‐Hua S., Khalili, Mandana, Fontana, Robert J., Yim, Colina, Wahed, Abdus S., Fried, Michael W., Hoofnagle, Jay H., Niu, Jianghe, Javaid, Asad, Nasir, Bilal, Susheela, Ammu, Nasser, Imad, Donovan, Arley, Rusibamayila, Nifasha, Foley, Cara, Stahler, Alisha C., Stadheim, Linda, Lake, John, Lacher, Philip, Rushing, Kathryn, DeMarco Shaw, Debra, Kessels, Lisa, Klebert, Michael K., Noureldin, Seham, La, Danie, Liu, Lucie, Kaznowski, Diana, Chen, Jiayun, Huang, Fengfei, Vladutu, Doinita, Cerocchi, Orlando, Rowan, Debra, Bass, Sheila, Lilly, Barbara, French, Samuel, Peacock, Velma, Geffen, David, Peters, Marion, Shobe, Ashley, Davis, Rayshawnda, Kuras, Romuald, Ayala, Claudia, Lau, Ivy, Podolskaya, Veronika, Bakonyi, Anna, DeVole, Nata, McKenna, Barbara, Choi, Karen, Oberhelman, Kelly, Kaza, Sravanthi, Moran, Isabel, Huddleston, Leslie, Wong, Richmond, Barritt, A. Sidney, Marsh, Tiffany, Metheny, Vikki, Cardona, Danielle, Smith, Paula G., Hofmann, Charlotte, Wolfstone, Alycia, Mooney, Jody, Cardona‐Gonzalez, Lupita, Fryzek, Nancy, Rivera, Elenita, Morris, Nevitt, Haynes‐Williams, Vanessa, Huang, Amy, Nadal, Catherine, Norman‐Wheeler, Jaha, Sherker, Averell H., Torrance, Rebecca J., Hall, Sherry R., Valiga, Mary E., Torrey, Keith, Levine, Danielle, Keith, James, Betts, Michael, Montaner, Luis J., Averbach, Frani, Haller, Tamara, Hardison, Regina, Kelley, Stephanie, Lalama, Christina, Lawlor, Sharon, Lombardero, Manuel, Pelesko, Andrew, Stoliker, Donna, Weiner, Melissa, Zadorozny, Ella, Zhao, Qian

“…Summary Background Patient‐reported outcomes (PROs) such as health‐related quality of life (HRQoL) and symptoms associated with chronic hepatitis B viral (HBV)…”
Get full text

Liver injury is associated with mortality in sickle cell disease by Feld, J. J., Kato, G. J., Koh, C., Shields, T., Hildesheim, M., Kleiner, D. E., Taylor, J. G., Sandler, N. G., Douek, D., Haynes‐Williams, V., Nichols, J. S., Hoofnagle, J. H., Jake Liang, T., Gladwin, M. T., Heller, T.

“…Summary Background Increased life expectancy in sickle cell disease (SCD) has resulted in greater recognition of the consequences of repeated intravascular…”
Get full text

Long‐term outcome of chronic hepatitis C after sustained virological response to interferon‐based therapy by Koh, C., Heller, T., Haynes‐Williams, V., Hara, K., Zhao, X., Feld, J. J., Kleiner, D. E., Rotman, Y., Ghany, M. G., Liang, T. J., Hoofnagle, J. H.

“…Summary Background Although the short‐term benefits of a sustained virological response (SVR) to interferon‐based therapies of chronic hepatitis C (CHC) are…”
Get full text

Understanding early serum hepatitis D virus and HBsAg kinetics during pegylated interferon-alfa therapy via mathematical modeling by Guedj, Jeremie, Rotman, Yaron, Cotler, Scott J., Koh, Christopher, Schmid, Peter, Albrecht, Jeff, Haynes-Williams, Vanessa, Liang, Jake T., Hoofnagle, Jay H., Heller, Theo, Dahari, Harel

“…There is little information on the early kinetics of hepatitis delta virus (HDV) and hepatitis B surface antigen (HBsAg) during interferon-α therapy. Here a…”
Get full text

Comparing Pain in Patients Undergoing Percutaneous Versus Transjugular Techniques of Liver Biopsy by Haynes-Williams, Vanessa

“…No study was found in the initial review of the literature comparing pain experienced by patients using the medical technique of Percutaneous Liver Biopsy…”
Get full text

Ribavirin improves early responses to peginterferon through enhanced interferon signaling by Feld, Jordan J., Lutchman, Glen A., Heller, Theo, Hara, Koji, Pfeiffer, Julie K., Leff, Richard D, Meek, Claudia, Rivera, Maria, Ko, Myung, Koh, Christopher, Rotman, Yaron, Ghany, Marc G., Haynes-Williams, Vanessa, Neumann, Avidan U., Liang, T. Jake, Hoofnagle, Jay H.

Get full text

A functional serotonin transporter gene polymorphism and depressive effects associated with interferon-alpha treatment by Pierucci-Lagha, Amira, Covault, Jonathan, Bonkovsky, Herbert L, Feinn, Richard, Abreu, Christine, Sterling, Richard K, Fontana, Robert J, Kranzler, Henry R

“…Interferon-alpha (IFN-alpha) treatment frequently induces depression, potentially leading to early dose reductions or a shorter duration of treatment, which…”
Get full text